What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Gene
His main research concerns Immunology, T-cell leukemia, Leukemia, Virus and Internal medicine.
His Immunology research is multidisciplinary, relying on both Leukocytopenia, Pharmacology and In vivo.
His T-cell leukemia research is classified as research in Pathology.
His Leukemia study combines topics in areas such as Missense mutation, IL-2 receptor, Blood transfusion and Point mutation.
Kiyoshi Takatsuki combines subjects such as Antibody, Asymptomatic carrier and Lymphoma with his study of Virus.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology, Endocrinology and Messenger RNA.
His most cited work include:
- Adult T-cell leukemia: clinical and hematologic features of 16 cases (1939 citations)
- Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. (750 citations)
- Surface phenotype of Japanese adult T-cell leukemia cells characterized by monoclonal antibodies (386 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Immunology, Leukemia, Virology, Molecular biology and Internal medicine.
His Leukemia research is mostly focused on the topic T-cell leukemia.
His T-cell leukemia study is focused on Pathology in general.
The various areas that he examines in his Virology study include T cell, Serology and Provirus.
His Molecular biology research integrates issues from Cell culture, IL-2 receptor and Monoclonal antibody.
The Internal medicine study combines topics in areas such as Gastroenterology, Endocrinology and Surgery.
He most often published in these fields:
- Immunology (36.13%)
- Leukemia (21.36%)
- Virology (19.96%)
What were the highlights of his more recent work (between 1995-2011)?
- Immunology (36.13%)
- Internal medicine (19.76%)
- Leukemia (21.36%)
In recent papers he was focusing on the following fields of study:
Kiyoshi Takatsuki mostly deals with Immunology, Internal medicine, Leukemia, Pathology and Molecular biology.
His Immunology research incorporates elements of Leukocytopenia and Pharmacology.
The study incorporates disciplines such as Gastroenterology, Endocrinology and Surgery in addition to Internal medicine.
He works in the field of Leukemia, focusing on T-cell leukemia in particular.
His biological study spans a wide range of topics, including Interleukin 2 and Cancer research.
In his study, which falls under the umbrella issue of Molecular biology, In vivo and Apoptosis is strongly linked to Cell culture.
Between 1995 and 2011, his most popular works were:
- Biallelic and Heterozygous Point Mutations in the Runt Domain of theAML1/PEBP2B Gene Associated With Myeloblastic Leukemias (380 citations)
- Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization on chromosome 2 (329 citations)
- Role of neutrophils in spinal cord injury in the rat (303 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
Kiyoshi Takatsuki mainly investigates Immunology, Leukemia, Pharmacology, Molecular biology and Internal medicine.
His Immunology research is multidisciplinary, incorporating elements of Leukocytopenia, Stem cell and Pathology.
His research in Leukemia is mostly focused on T-cell leukemia.
His research investigates the connection with T-cell leukemia and areas like Cancer research which intersect with concerns in Janus kinase 3 and JAK-STAT signaling pathway.
His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology, Cycloheximide, Surgery and Enhancer binding.
His Virus study incorporates themes from Antibody and Provirus.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
